Published in J Allergy Clin Immunol on March 30, 2012
Safety of Lymph Node Injection for Allergen Immunotherapy | NCT01982474
Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy | NCT04200989
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med (2012) 1.08
Molecular approach to allergy diagnosis and therapy. Yonsei Med J (2014) 1.01
Safety of engineered allergen-specific immunotherapy vaccines. Curr Opin Allergy Clin Immunol (2012) 0.97
Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Crit Rev Immunol (2013) 0.90
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol (2016) 0.89
Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance. AAPS J (2014) 0.89
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy. Curr Treat Options Allergy (2013) 0.89
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy. Curr Treat Options Allergy (2014) 0.86
Intralymphatic immunotherapy. World Allergy Organ J (2015) 0.86
Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis. Mol Ther Methods Clin Dev (2014) 0.84
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial. Respir Res (2016) 0.84
Emerging therapies for food allergy. J Clin Invest (2014) 0.83
Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study. Clin Transl Allergy (2016) 0.83
New routes for allergen immunotherapy. Hum Vaccin Immunother (2012) 0.81
The dual nature of interleukin-10 in pemphigus vulgaris. Cytokine (2014) 0.81
Food allergy diagnosis and therapy: where are we now? Immunotherapy (2013) 0.79
Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis. AAPS J (2014) 0.78
Designing a multimer allergen for diagnosis and immunotherapy of dog allergic patients. PLoS One (2014) 0.78
A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies. Allergy Asthma Immunol Res (2017) 0.78
Mechanisms of immune tolerance to allergens in children. Korean J Pediatr (2013) 0.77
Is clinical tolerance possible after allergen immunotherapy? Curr Allergy Asthma Rep (2015) 0.76
New treatments for allergen immunotherapy. World Allergy Organ J (2014) 0.76
Novel developments in the mechanisms of immune tolerance to allergens. Hum Vaccin Immunother (2012) 0.76
Immune responses to inhalant Mammalian allergens. Front Immunol (2014) 0.76
Is The Allergen Really Needed in Allergy Immunotherapy? Curr Treat Options Allergy (2015) 0.76
New vaccines for Mammalian allergy using molecular approaches. Front Immunol (2014) 0.76
Allergen immunotherapy: routes, safety, efficacy, and mode of action. Immunotargets Ther (2013) 0.75
Intralymphatic immunotherapy and vaccination in mice. J Vis Exp (2014) 0.75
New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates. Curr Opin Allergy Clin Immunol (2013) 0.75
Targeted vaccines against feline dander could be the cat's meow. Nat Med (2012) 0.75
Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms. J Allergy Clin Immunol (2016) 0.75
Allergen-specific intralymphatic immunotherapy in human and animal studies. Asia Pac Allergy (2017) 0.75
Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation (2008) 5.20
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood (2008) 2.65
IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol (2009) 2.56
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis (2003) 2.49
GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol (2007) 2.49
Allergic disease and sensitization in Steiner school children. J Allergy Clin Immunol (2005) 2.44
Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med (2007) 2.21
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol (2011) 2.06
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2007) 2.05
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03
Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol (2009) 2.03
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol (2013) 1.96
Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol (2004) 1.92
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med (2008) 1.91
Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med (2006) 1.88
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2011) 1.84
Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol (2006) 1.84
Role of Treg in immune regulation of allergic diseases. Eur J Immunol (2010) 1.82
TH17 cells in the big picture of immunology. J Allergy Clin Immunol (2007) 1.78
IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol (2005) 1.74
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med (2009) 1.73
Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis (2011) 1.70
Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol (2003) 1.68
Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J (2002) 1.66
Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis (2012) 1.62
Extending the phenotypes associated with DICER1 mutations. Hum Mutat (2011) 1.61
Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med (2009) 1.57
Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol (2007) 1.57
Evaluation of IgE antibodies to recombinant peanut allergens in patients with reported reactions to peanut. Int Arch Allergy Immunol (2011) 1.54
Wheat and maize thioredoxins: a novel cross-reactive cereal allergen family related to baker's asthma. J Allergy Clin Immunol (2006) 1.51
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J (2013) 1.51
Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol (2006) 1.45
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A (2008) 1.44
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol (2013) 1.43
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol (2005) 1.38
Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol (2010) 1.37
A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2013) 1.36
Impact of Bt maize pollen (MON810) on lepidopteran larvae living on accompanying weeds. Mol Ecol (2006) 1.35
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol (2010) 1.34
Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol (2006) 1.34
Cat IgA, representative of new carbohydrate cross-reactive allergens. J Allergy Clin Immunol (2007) 1.34
Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression. Proc Natl Acad Sci U S A (2011) 1.33
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD. Graefes Arch Clin Exp Ophthalmol (2014) 1.28
Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. J Allergy Clin Immunol (2012) 1.28
Not all farming environments protect against the development of asthma and wheeze in children. J Allergy Clin Immunol (2007) 1.27
T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J (2003) 1.24
Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol (2009) 1.24
Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations. Radiology (2010) 1.23
Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev (2005) 1.22
Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev (2005) 1.22
Traffic-related air pollution and development of allergic sensitization in children during the first 8 years of life. J Allergy Clin Immunol (2011) 1.21
Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol (2011) 1.20
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. J Control Release (2010) 1.20
Abductor tendon tears are associated with hypertrophy of the tensor fasciae latae muscle. Skeletal Radiol (2012) 1.19
Regulatory NK cells suppress antigen-specific T cell responses. J Immunol (2008) 1.18
Antigen kinetics determines immune reactivity. Proc Natl Acad Sci U S A (2008) 1.17
Immune regulation by histamine. Curr Opin Immunol (2002) 1.16
MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol (2013) 1.16
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol (2010) 1.16
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol (2011) 1.15
Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol (2005) 1.14
Peanut component Ara h 8 sensitization and tolerance to peanut. J Allergy Clin Immunol (2012) 1.14
Biological and genetic interaction between tenascin C and neuropeptide S receptor 1 in allergic diseases. Hum Mol Genet (2008) 1.14